Italia markets closed

Agilent Technologies, Inc. (A)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a portafoglio
126,21+0,18 (+0,14%)
Alla chiusura: 4:00PM EST

126,21 0,00 (0,00%)
Dopo ore: 5:12PM EST

Agilent Technologies, Inc.

5301 Stevens Creek Boulevard
Santa Clara, CA 95051
United States
800 227 9770
http://www.agilent.com

Settore/iHealthcare
SettoreDiagnostics & Research
Impiegati a tempo pieno16.400

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Michael R. McMullenCEO, Pres & Director2,96M1,26M1961
Mr. Robert W. McMahonSr. VP & CFO2,16MN/D1969
Mr. Michael TangSr. VP, Gen. Counsel & Sec.991,5kN/D1974
Mr. Jacob ThaysenSr. VP and Pres of Life Sciences & Applied Markets Group1,04MN/D1975
Mr. Rodney GonsalvesPrincipal Accounting Officer, VP & Corp. ControllerN/DN/D1966
Dr. Darlene J. S. SolomonCTO & Sr. VPN/DN/D1959
Mr. Ankur DhingraVP of Investor RelationsN/DN/DN/D
Mr. Dominique P. GrauSr. VP of HR & Global CommunicationsN/DN/D1959
Mr. Richard A. BurdsallSr. VP of Global Infrastructure ServicesN/DN/D1963
Ms. Yvonne MackieMD of UK & Ireland Operations and VP of HR - EuropeN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2019 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment to produce synthesized oligonucleotide. It also offers immunohistochemistry, in situ hybridization, and hematoxylin and eosin staining and special staining; instruments, consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. It has collaboration agreement with SGS AXYS. The company was incorporated in 1999 and is headquartered in Santa Clara, California.

Governance aziendale

L'ISS Governance QualityScore di Agilent Technologies, Inc. al 1 dicembre 2020 è 6. I criteri di valutazione fondamentali sono revisione: 2; Consiglio di Amministrazione: 4; diritti degli azionisti: 8; retribuzione: 3.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.